Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proportion of stroke, intracranial bleeding and all-cause death in the short (at 3 months), mid-term (at 12 months) as well as long term (at 24 months) after ischemic stroke or transient ischemic attack in an unselected urban population in Germany.
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample
Patients with known atrial fibrillation and acute ischemic stroke or transient ischemic attack
|Type||Measure||Time Frame||Safety Issue|
|Primary||Patient self-reported persistence to oral anticoagulants (novel oral anticoagulants or vitamin K antagonists) in stroke patients with AF at 12 months after ischemic stroke or TIA||12 months||No|